BIO-ANGLE VACS SDN BHD (BAV) is a Malaysian company established in 2013 specializing in the global development, manufacturing, and distribution of biotechnology based products, veterinary pharmaceutical and health supplements. It holds a unique position as the sole company globally dedicated to this field. BAV collaborates with renowned institutions like Universiti Putra Malaysia (UPM) and the Malaysian Genome and Vaccine Institute (MGVI) to advance livestock health and disease prevention.

​

For now, BAV has secured few on-going business deals with our local current clients whereas the international business deals shall be closed upon the completion of our proposed GMP facilities. BAV also has some potential clients in the pipeline who are keen to purchase our products.

​

BAV has already signed sale and purchase agreements with 5 overseas companies to market 270,000 bottles of STVac to China, Nigeria, Kenya, Indonesia, Republic of Chad and Republic of Uganda with discussions underway for other markets. The market value of animal vaccines in the world is estimated at around USD 12 billion. The total population of goats worldwide is 2.2 billion. BAV is only targeting 25 million goats equivalent to 1% of the total population which has the potential to generate an income of USD 200 million per year.